Skip to content

Smartphone based Monitoring and cognition Modification Against Recurrence of Depression (SMARD) – Workpackage 1

Smartphone based Monitoring and cognition Modification Against Recurrence of Depression – Workpackage 1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26184
Enrollment
60
Registered
2021-08-12
Start date
2017-04-13
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Remitted) Major Depressive Disorder

Interventions

None

Sponsors

Radboudumc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years 2. Recurrent MDD diagnoses (according to DSM-IV and SCID) 3. At least 3 previous MDD-episodes (assessed with the SCID-interview) 4. In stable remission: does not meet criteria for a current MDD episode (SCID-interview) =8 weeks and a Hamilton Depression Rating Scale score =10 5. In possession of smartphone and experienced in use thereof

Exclusion criteria

Exclusion criteria: 1. Diagnosis of bipolar, primary psychotic or borderline personality disorder or strong suspicion of this type of disorder 2. Primary diagnosis of substance use or anxiety disorder with secondary MDD 3. Electroconvulsive therapy within two months before inclusion 4. Average alcohol intake of >3 units/day 5. Daily use of benzodiazepines (=5mg diazepam or equivalent) 6. Incompatible smartphone to install BEHAPP

Design outcomes

Primary

MeasureTime frame
1.Focus-groups BEHAPP acceptability – saturation of ideas obtained in the focus-groups 2.BEHAPP and prediction of prospective recurrence during an observational follow-up of 1.5 years

Secondary

MeasureTime frame
1. BEHAPP and prediction of recurrence during follow-up related to residual symptoms (HDRS17) and changes in baseline ESM-based symptom-networks (daily positive and negative affect measurement) across a six-day period

Contacts

Public ContactHenricus G. Ruhe

Radboudumc & Donders Institute for Brain, Cognition and Behavior, Radboud University

eric.ruhe@radboudumc.nl+31 6 51508197

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 5, 2026